234 filings
Page 3 of 12
8-K
l505lqdc3qpv05n
28 Sep 20
Entry into a Material Definitive Agreement
4:01pm
8-K
d8hw rnojejwd56ykyg
2 Sep 20
Other Events
4:02pm
8-K
4kgsqv8aatr6i5jybd
19 Aug 20
Regulation FD Disclosure
4:02pm
8-K
q6hwvdrgu rj95
10 Aug 20
Casi Pharmaceuticals Announces Second Quarter 2020
4:01pm
8-K
n9f1v
24 Jul 20
Casi Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:05pm
8-K
rsinga eivdivdzl98rn
21 Jul 20
Results of Operations and Financial Condition
4:13pm
8-K
3f5ddo64415sv gmu0h
17 Jun 20
Submission of Matters to a Vote of Security Holders
5:14pm
8-K
eyh0i 1e4jj
12 May 20
Casi Pharmaceuticals Announces First Quarter 2020
12:00am
8-K
r0fed2005pua1jx8lx
16 Mar 20
Casi Pharmaceuticals Announces Full Year 2019 Financial Results
4:01pm
8-K
8k4expbqthjj2 v6
6 Mar 20
Departure of Directors or Certain Officers
4:01pm
8-K
xsthydp116z5p9xozre
20 Feb 20
Departure of Directors or Certain Officers
4:02pm
8-K
31o6ry9i acpaj
26 Nov 19
Entry into a Material Definitive Agreement
4:01pm
8-K
gc045 luf
13 Nov 19
Departure of Directors or Certain Officers
4:01pm
8-K
y42ug4fbrad5x
12 Nov 19
CASI Pharmaceuticals Announces Third Quarter 2019 Financial Results
10:01am
8-K
bj5zwbv 7rmncpsp
1 Nov 19
Other Events
4:51pm
8-K/A
ixittj
25 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
dn094mrihv5d8
11 Sep 19
Departure of Directors or Certain Officers
4:01pm
8-K
a1br5s kcnakv
23 Aug 19
Other Events
5:25pm
8-K
1j5jl6ye
9 Aug 19
Casi Pharmaceuticals Announces Second Quarter and First Half 2019 Financial and Business Results
9:00am
8-K
spq 3csuffu6czwuzbx
19 Jul 19
Entry into a Material Definitive Agreement
5:00pm